Subscribe
Sign In
Continue to Site
»
Site will load in
15
seconds
Continue to Site »
X
Finance
All 4Front Subsidiaries File for Court-Appointed Receiver
The company intends to continue operating during the receivership process and hopes the process will generate value for stakeholders.
Green Thumb Industries Reports $280M in Q1 Revenue
The cannabis company also reported $74 million in cash flow from operations and a GAAP net income of $8 million.
Tilray Brands Announces Proposed Reverse Stock Split
The global cannabis company also announced a corresponding special stockholders meeting.
Tilray Brands Reports Quarterly Financial Results, Confirms No Tariff Impacts
The global cannabis company generated a net revenue of $186 million in the third fiscal quarter, verifying it has no current impacts from U.S. tariffs.
SNDL Reports Q4 and Full Year 2024 Financial and Operational Results
The company reported record full-year net revenue, gross profit and gross margin, as well as positive cash flow and free cash flow.
Ascend Wellness Reports $562 Million in 2024 Revenue
The cannabis company also reported its second full year of positive cash from operations and positive free cash flow.
The Cannabist Co. Reports $459 Million in 2024 Revenue
The cannabis company continues to complete divestitures, reduce operating and overhead costs, and refine its inventory assortment.
Green Thumb Industries Announces $50 Million Share Repurchase Program
The program authorizes the cannabis company to repurchase up to nearly 10.6 million subordinate voting shares during the next 12 months.
Green Thumb Industries Refinances Senior Debt, Closing on $150 Million Syndicated Credit Facility
The cannabis company intends to use the proceeds along with existing cash to retire its $225 million senior secured debt.
Ascend Wellness Holdings Removes CEO, Terminates CFO
The cannabis company appointed board Director Samuel Brill to replace John Hartman as CEO. The company also appointed a new president and CFO.
TerrAscend Offers $10 Million Share Repurchase Program
The company is authorized to repurchase up to 10 million shares but is not obligated to purchase any shares during the 12-month stock buyback program.
Curaleaf Reports $342 Million in Q2 Revenue
The global cannabis company now operates in 15 countries.
Page 1 of 183
Next Page
